These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30110924)
81. A clinical survey of hydrocephalus and current treatment for hydrocephalus in Japan: analysis by nationwide questionnaire. Miyake H; Ohta T; Kajimoto Y; Ogawa D Childs Nerv Syst; 1999 Aug; 15(8):363-8. PubMed ID: 10447603 [TBL] [Abstract][Full Text] [Related]
82. Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus. Bir SC; Konar S; Maiti TK; Kalakoti P; Bollam P; Nanda A Childs Nerv Syst; 2016 Aug; 32(8):1405-14. PubMed ID: 27278283 [TBL] [Abstract][Full Text] [Related]
83. Free floating ventricular shunt catheter between lateral ventricles: a case report of an unusual ventriculoperitoneal shunt complication. Erol FS; Cakin H; Ozturk S; Donmez O; Kaplan M Turk Neurosurg; 2013; 23(6):821-3. PubMed ID: 24310472 [TBL] [Abstract][Full Text] [Related]
84. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Hansen AR; Volpe JJ; Goumnerova LC; Madsen JR Pediatr Neurol; 1997 Oct; 17(3):213-7. PubMed ID: 9390696 [TBL] [Abstract][Full Text] [Related]
85. Symptomatic communicating hydrocephalus in a contemporary cohort of high grade glioma patients. Beez T; Burgula S; Kamp M; Rapp M; Steiger HJ; Sabel M Br J Neurosurg; 2018 Feb; 32(1):68-72. PubMed ID: 29160137 [TBL] [Abstract][Full Text] [Related]
86. Volumetric measurements in the detection of reduced ventricular volume in patients with normal-pressure hydrocephalus whose clinical condition improved after ventriculoperitoneal shunt placement. Anderson RC; Grant JJ; de la Paz R; Frucht S; Goodman RR J Neurosurg; 2002 Jul; 97(1):73-9. PubMed ID: 12134935 [TBL] [Abstract][Full Text] [Related]
87. Comparison of hydrocephalus metrics between infants successfully treated with endoscopic third ventriculostomy with choroid plexus cauterization and those treated with a ventriculoperitoneal shunt: a multicenter matched-cohort analysis. Dewan MC; Lim J; Gannon SR; Heaner D; Davis MC; Vaughn B; Chern JJ; Rocque BG; Klimo P; Wellons JC; Naftel RP J Neurosurg Pediatr; 2018 Apr; 21(4):339-345. PubMed ID: 29393809 [TBL] [Abstract][Full Text] [Related]
88. Comparison of the use of ventricular access devices and ventriculosubgaleal shunts in posthaemorrhagic hydrocephalus: systematic review and meta-analysis. Fountain DM; Chari A; Allen D; James G Childs Nerv Syst; 2016 Feb; 32(2):259-67. PubMed ID: 26560885 [TBL] [Abstract][Full Text] [Related]
89. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants. Willis BK; Kumar CR; Wylen EL; Nanda A Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252 [TBL] [Abstract][Full Text] [Related]
90. Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis. Lee MH; Lee JI J Korean Neurosurg Soc; 2011 Oct; 50(4):385-7. PubMed ID: 22200024 [TBL] [Abstract][Full Text] [Related]
91. Anaplastic ependymoma metastases though a ventriculoperitoneal shunt. St Jeor JD; Thacker PG; Benson JC; Hull NC Radiol Case Rep; 2020 Jun; 15(6):650-654. PubMed ID: 32280394 [TBL] [Abstract][Full Text] [Related]
92. Intraventricular Shunt as a Treatment for Entrapped Temporal Horn After Removal of Ventricular Meningioma: A Report of Two Cases. Xie J; Zeng Z; Wang S Cureus; 2024 Apr; 16(4):e57561. PubMed ID: 38707096 [TBL] [Abstract][Full Text] [Related]
93. Primary intraventricular central nervous system lymphoma in an immunocompetent patient. Suri V; Mittapalli V; Kulshrestha M; Premlani K; Sogani SK; Suri K J Pediatr Neurosci; 2015; 10(4):393-5. PubMed ID: 26962354 [TBL] [Abstract][Full Text] [Related]
94. Neuroendoscopic Resection of Intraventricular Tumors and Cysts through a Working Channel with a Variable Aspiration Tissue Resector: A Feasibility and Safety Study. Nduom EK; Sribnick EA; Ormond DR; Hadjipanayis CG Minim Invasive Surg; 2013; 2013():471805. PubMed ID: 23844287 [TBL] [Abstract][Full Text] [Related]
95. Neurosurgical Device Implantation for Neurooncologic Patients: What To Avoid? Chaskis E; Sadeghi N; De Witte O; Lefranc F World Neurosurg; 2019 Apr; 124():298-303. PubMed ID: 30684711 [TBL] [Abstract][Full Text] [Related]
96. Why flushing the valve cannot be a reliable method to evaluate the ventriculoperitoneal shunt function? Nejat F; El-Khashab M Iran J Pediatr; 2011 Dec; 21(4):556. PubMed ID: 23056850 [No Abstract] [Full Text] [Related]
97. Recurrent breast cancer in a patient with a ventriculoperitoneal shunt. Copeland-Halperin LR; Cohen RA Case Rep Surg; 2015; 2015():659395. PubMed ID: 25648450 [TBL] [Abstract][Full Text] [Related]
98. Intraventricular hemorrhage: A catastrophic complication after removal of old ventriculoperitoneal shunt. Singh M; Gundamaneni SK; Sasidharan GM; Madhugiri VS; Rathakrishnan RKV Asian J Neurosurg; 2017; 12(3):580-581. PubMed ID: 28761549 [No Abstract] [Full Text] [Related]
99. Subgaleal coiling of the proximal and distal components of a ventriculoperitoneal shunt. Kloss BT; Hart DM; Secreti L Int J Emerg Med; 2012 Mar; 5(1):15. PubMed ID: 22424557 [TBL] [Abstract][Full Text] [Related]